Provision of Fluorescent in situ Hybridisation (FISH) Services

St James's Hospital

The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James's Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing:
— Her2 gene amplification found in Breast/Gastric/Colorectal Cancer
— Gene rearrangement /translocations found in Lymphomas
— Alk and ROS1 gene rearrangement found in NSCLC
The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.
Future Development
Possible introduction of additional esoteric FISH testing for Lymphoma nationally
— DUSP22, TP63 rearrangements
— 11q aberration.
Possible development of Myeloma FISH service.

Deadline

The time limit for receipt of tenders was 2018-01-10. The procurement was published on 2017-11-29.

Suppliers

The following suppliers are mentioned in award decisions or other procurement documents:

• Leica Microsystems (Uk) Ltd

Who?

• St James's Hospital

What?

• Architectural, construction, engineering and inspection services › Laboratory services
• Biochemical analysers › Biomedical equipment
• Collector and collection bags, drainage and kits › Medical kits › Diagnostic kits
• Diagnostic devices › Diagnostic systems
• Installation services of medical and surgical equipment › Installation services of laboratory equipment
• Medical practice services › Medical specialist services
• Miscellaneous health services › Services provided by medical laboratories
• Various medicinal products › Diagnostic agents

Where?

• Éire/Ireland

Procurement history

Date	Document
2017-11-29	Contract notice
2019-08-07	Contract award notice

Contract notice (2017-11-29)
Object
Scope of the procurement
Title: Laboratory, optical and precision equipments (excl. glasses)
Short description:

The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James's Hospital has provided a hospital and national service since the 2010. The service is staffed by two medical scientists. Currently the service offers the following assays for diagnostics and predictive testing: — Her2 gene amplification found in Breast/Gastric/Colorectal Cancer — Gene rearrangement /translocations found in Lymphomas — Alk and ROS1 gene rearrangement found in NSCLC The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material. Future Development Possible introduction of additional esoteric FISH testing for Lymphoma nationally — DUSP22, TP63 rearrangements — 11q aberration. Possible development of Myeloma FISH service.

Notice metadata
Original language: English 🗣️
Document type: Contract notice
Nature of contract: Supplies
Regulation: European Union
Common procurement vocabulary (CPV)
Code: Laboratory, optical and precision equipments (excl. glasses) 📦
Additional CPV: Medical equipments, pharmaceuticals and personal care products 📦
Place of performance
NUTS region: Éire/Ireland 🏙️

Procedure
Procedure type: Competitive dialogue
Type of bid: Submission for all lots
Award criteria
The most economic tender

Contracting authority
Identity
Country: Ireland 🇮🇪
Awarding authority type: Body governed by public law
Awarding authority name: St James's Hospital
Postal address: James Street
Postal code: 8
Postal town: Dublin
Contact
Internet address: http://www.stjames.ie 🌏
E-mail: dgunning@stjames.ie 📧
Phone: +353 14284707 📞
URL for documents: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=122150&B=ETENDERS_SIMPLE 🌏
URL for participation: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=122150&B=ETENDERS_SIMPLE 🌏

Reference
Dates
Date dispatched: 2017-11-29 📅
Submission deadline: 2018-01-10 📅
Publication date: 2017-11-30 📅
Identifiers
Notice number: 2017/S 230-479093
OJ-S issue: 230

Object
Scope of the procurement
Short description:

— Her2 gene amplification found in Breast/Gastric/Colorectal Cancer

— Gene rearrangement /translocations found in Lymphomas

— Alk and ROS1 gene rearrangement found in NSCLC

The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material.

Future Development

Possible introduction of additional esoteric FISH testing for Lymphoma nationally

— DUSP22, TP63 rearrangements

— 11q aberration.

Possible development of Myeloma FISH service.

Estimated total value: 850 000 EUR 💰
Estimated value excluding VAT: 850 000 EUR 💰
Duration: 60 months
Place of performance
Main site or place of performance: St James's Hospital.

Procedure
Minimum number of candidates: 3
Time of receipt of tenders: 12:00
Date of dispatch of invitations: 2018-03-02 📅
Languages in which tenders or requests to participate may be submitted: English 🗣️

Contracting authority
Identity
National registration number: N/a
Contact
Contact point: David Gunning
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/395 🌏
Documents URL: http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=122150&B=ETENDERS_SIMPLE 🌏

Complementary information
Review body
Name: Hig Court
Postal town: Dublin
Country: Ireland 🇮🇪
Source: OJS 2017/S 230-479093 (2017-11-29)

Contract award notice (2019-08-07)
Object
Scope of the procurement
Short description:

The Fluorescent in-situ hybridisation (FISH) laboratory in the Histopathology Department at St. James’s Hospital has provided a hospital and national service since the 2010. The service is staffed by 2 medical scientists. Currently the service offers the following assays for diagnostics and predictive testing: — Her2 gene amplification found in breast/gastric/colorectal cancer, — gene rearrangement/translocations found in lymphomas, — Alk and ROS1 gene rearrangement found in NSCLC. The Fluorescent in-situ hybridisation (FISH) technique is performed as a semi-automated assay, on formalin fixed paraffin embedded material. Future development Possible introduction of additional esoteric FISH testing for Lymphoma nationally — DUSP22, TP63 rearrangements, — 11q aberration. Possible development of Myeloma FISH service.

Total value of the procurement: 200 000 EUR 💰
Notice metadata
Document type: Contract award notice

Procedure
Type of bid: Not applicable

Contracting authority
Identity
Postal code: Dublin 8

Reference
Dates
Date dispatched: 2019-08-07 📅
Publication date: 2019-08-12 📅
Identifiers
Notice number: 2019/S 154-379584
Refers to notice: 2017/S 230-479093
OJ-S issue: 154

Object
Scope of the procurement
Short description:

— Her2 gene amplification found in breast/gastric/colorectal cancer,

— gene rearrangement/translocations found in lymphomas,

— Alk and ROS1 gene rearrangement found in NSCLC.

Future development

— DUSP22, TP63 rearrangements,

— gene rearrangement /translocations found in lymphomas,

Possible introduction of additional esoteric FISH testing for lymphoma nationally

Procedure
Award criteria
Quality criterion (name): Quality
Quality criterion (weighting): 60
Cost criterion (name): Price
Cost criterion (weighting): 40

Award of contract
Date of contract conclusion: 2019-08-07 📅
Name: Leica Microsystems (UK) Ltd
National registration number: 476611
Postal address: Larch House, Woodlands Business Park, Breckland, Linford W
Postal town: Milton Keynes
Postal code: MK14 6FG
Country: United Kingdom 🇬🇧
Phone: +44 1908246246 📞
E-mail: lbstenders.uk@leicabiosystems.com 📧
Country: Éire/Ireland 🏙️
Internet address: http://www.leica-microsystems.com 🌏
Total value of the procurement: 200 000 EUR 💰
Information about tenders
Number of tenders received: 3

Complementary information
Review body
Postal address: Dublin
Source: OJS 2019/S 154-379584 (2019-08-07)

New procurements in related categories 🆕

Laboratory, optical and precision equipments (excl. glasses) (16 new procurements)